Observational studyMultiple sclerosis (Houndmills, Basingstoke, England)2020

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.

Elias S Sotirchos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.